Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
about
Using expression and genotype to predict drug response in yeastIntegrating Epigenomics into Pharmacogenomic StudiesRadiation-induced apoptosis varies among individuals and is modified by sex and age.Cell-based Models for Discovery of Pharmacogenomic Markers of Anticancer Agent Toxicity.Pharmacogenetics and pharmacogenomics of anticancer agents.Pharmacogenomics of cisplatin-induced ototoxicityAncestry-related differences in gene expression: findings may enhance understanding of health disparities between populations.Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.Identification of genomic regions contributing to etoposide-induced cytotoxicity.Genetic variants associated with cisplatin-induced ototoxicity.Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.Pediatric perspective on pharmacogenomics.5-Fluorouracil Induce the Expression of TLR4 on HCT116 Colorectal Cancer Cell Line Expressing Different Variants of TLR4.Human lymphoblastoid cell lines: a goldmine for the biobankomics era.Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.
P2860
Q28476059-0851B45B-45CC-4802-A083-728035605538Q33980155-05F8C02F-47B0-4CC5-891C-A6E3255F7EF7Q34463885-A38513FF-15C2-4035-BE7B-138E2E71E4EFQ34789161-57914724-5DAC-4719-9BDA-9384C094849EQ35030489-454A8911-2DBA-40FF-9A18-8CAAA06CE106Q35553827-2D43E12B-3BEC-40F4-A219-E29DB04C558BQ37149646-B1DE0E35-F461-48AE-A1A7-7BD0575D8D0BQ37237505-78A4E2ED-C156-4B12-9D62-EEB8D6C247FAQ37271887-569A744C-6482-46D9-8231-CE4FDCE769E4Q37293994-D1F69996-DC30-4AD0-BA7F-6B1ADD3766B1Q37390119-10577912-2A5D-43D5-8B99-6BE488F60C0EQ37414536-538D25F3-851A-4537-B5E8-B109D122A437Q37658863-67EFDE19-D28D-4C93-8404-7527825F6942Q38162869-9E594E31-6478-4EFA-A563-5882C232B64BQ39061490-7FD6FA35-316B-45B0-A853-32B9A5D899C3Q39520813-AD5D3E10-ACAA-4655-A279-B4A7ED9FEE13Q47309064-09AA0E22-10AE-446E-B88C-794263EB6D63
P2860
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
@en
type
label
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
@en
prefLabel
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
@en
P2860
P1433
P1476
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
@en
P2093
Christine M Hartford
M Eileen Dolan
P2860
P304
P356
10.2217/14622416.8.9.1159
P577
2007-09-01T00:00:00Z